The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGILE THERAPEUTICS INC | COM | 00847L100 | 15,883 | 2,275,455 | SH | SOLE | 2,275,455 | 0 | 0 | ||
| CEMPRA INC | COM | 15130J109 | 28,872 | 1,193,060 | SH | SOLE | 1,193,060 | 0 | 0 | ||
| CHIMERIX INC. | COM | 16934W106 | 2,620 | 472,943 | SH | SOLE | 472,943 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC. | COM | 29664W105 | 22,674 | 1,637,125 | SH | SOLE | 1,637,125 | 0 | 0 | ||
| INTERSECT ENT INC | COM | 46071F103 | 3,936 | 248,498 | SH | SOLE | 248,498 | 0 | 0 | ||
| LOMBARD MED INC | COM | G55598109 | 417 | 443,182 | SH | SOLE | 443,182 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 105,477 | 4,028,920 | SH | SOLE | 4,028,920 | 0 | 0 | ||
| PERNIX THERAPEUTICS HLDGS IN | COM | 71426V108 | 1,246 | 2,010,000 | SH | SOLE | 2,010,000 | 0 | 0 | ||
| T2 BIOSYSTEMS INC | COM | 89853L104 | 20,496 | 2,830,992 | SH | SOLE | 2,830,992 | 0 | 0 | ||
| TRANSENTERIX INC. | COM NEW | 89366M201 | 14,088 | 8,335,819 | SH | SOLE | 8,335,819 | 0 | 0 | ||
| VERSARTIS INC | COM | 92529L102 | 30,925 | 2,524,465 | SH | SOLE | 2,524,465 | 0 | 0 | ||
| ZELTIQ AESTHETICS INC | COM | 98933Q108 | 63,133 | 1,609,727 | SH | SOLE | 1,609,727 | 0 | 0 | ||
| PARATEK PHARMACEUTICALS INC | COM | 699374302 | 6,280 | 482,680 | SH | SOLE | 482,680 | 0 | 0 | ||
| ADMA BIOLOGICS INC | COM | 000899104 | 26,159 | 3,608,171 | SH | SOLE | 3,608,171 | 0 | 0 | ||
| AIMMUNE THERAPEUTICS INC. | COM | 00900T107 | 44,850 | 2,990,000 | SH | SOLE | 2,990,000 | 0 | 0 | ||
| CYNAPSUS THERAPEUTICS INC. | COM | 23257Y859 | 45,102 | 1,121,381 | SH | SOLE | 1,121,381 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC. | COM | 171757107 | 11,692 | 1,021,148 | SH | SOLE | 1,021,148 | 0 | 0 | ||
| PERNIX THERAPEUTICS HLDGS INC | DEBT | 71426VAK4 | 675 | 2,500,000 | PRN | SOLE | 2,500,000 | 0 | 0 | ||
| VIEWRAY INC. | COM | 92672L107 | 33,814 | 7,480,887 | SH | SOLE | 7,480,887 | 0 | 0 | ||
| SYROS PHARMACEUTICALS, INC. | COM | 87184Q107 | 7,054 | 508,565 | SH | SOLE | 508,565 | 0 | 0 | ||